Membrane Chromatography Market Size

Membrane Chromatography Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

The membrane chromatography market is expected to grow significantly, with the current market size projected at USD 0.16 billion in 2025, and expected to reach USD 0.66 billion by 2034, at a CAGR of 16.8% during the forecast period. This growth indicates a strong demand for advanced separation processes, especially in the field of biopharmaceuticals, where the need for efficient and scalable processes is becoming increasingly important. The increasing importance of bioprocessing and the increasing use of monoclonal antibodies and other biopharmaceuticals are driving the market. Technological developments, such as the development of new membrane materials and improved production processes, further increase the efficiency and effectiveness of membrane chromatography systems. The market is led by companies such as Merck KGaA, Sartorius AG, and Pall Corp., which have been active in the field of innovation, such as the establishment of strategic alliances, the establishment of new products, and the establishment of new production lines. These efforts not only strengthen their market positions, but also contribute to the overall growth of the membrane chromatography market.

Regional Market Size

Regional Deep Dive

The membrane chromatography market is growing at a significant rate in different regions. This growth is being driven by the rising demand for biopharmaceuticals, the technological advancements in the purification processes and the shift towards more efficient and cost-effective methods. In North America, the market is characterized by the strong presence of major players and a robust regulatory framework that supports innovation. In Europe, the market is diversified and characterized by stringent regulations and the need to implement sustainable practices. The Asia-Pacific region is emerging rapidly due to the growing investments in the biopharmaceutical sector and the improvement of the healthcare facilities. The Middle East and Africa (MEA) region is slowly growing and is characterized by the increasing investments in the health sector. The Latin American region is beginning to adopt membrane chromatography due to the growth in the biopharmaceutical sector.

North America

• The new guidance from the FDA on continuous processing has encouraged biopharmaceutical companies to use membrane chromatography because of its high efficiency and scalability.
• And now the companies like Merck and Pall are investing heavily in research and development, especially in the area of membranes, with the aim of improving selectivity and capacity.
• A close collaboration between academics and the pharmaceutical industry in Boston and San Francisco is fostering the development of new applications for chromatography.

Europe

• The European Medicines Agency (EMEA) has adopted new guidelines that encourage the use of advanced purification techniques, including membrane chromatography, in drug development.
• In this respect, the companies Sartorius and GE Healthcare are at the forefront in developing new membranes that are adapted to the special requirements of bioprocessing.
• In Europe, the market is influenced by the need for more sustainable production methods, with the aim of reducing the amount of waste and energy consumed in the biomanufacturing process.

Asia-Pacific

• China and India are stepping up their investments in biopharmaceutical manufacturing. This is bringing about a growing demand for efficient purification methods such as membrane chromatography.
• The government’s initiative to promote biotechnology and the Make in India programme has facilitated the introduction of advanced chromatographic techniques.
• Tosoh Bioscience, for example, has set up a local production unit in the region, which is now able to supply the growing demand for bioprocessing solutions.

MEA

• The UAE's Vision 2021 initiative is driving investments in the healthcare and biotechnology industries, which is boosting the market for chromatography membranes in the region.
• In recent years, local companies have begun to establish links with international companies to develop their biomanufacturing skills. The main focus of these collaborations is on membrane chromatography.
• In the last few years the regulations in the region have been gradually aligned with international standards. This will make it easier for local biopharmaceutical manufacturers to integrate advanced purification methods into their production.

Latin America

• Brazil’s National Health Surveillance Agency (ANVISA) is promoting the use of modern bioprocessing methods, including membrane chromatography.
• Biopharmaceutical companies in countries such as Argentina and Chile are increasingly aware of the advantages of chromatography on a membrane in the efficient purification of their products.
• Local universities and industry are collaborating in developing bioprocessing, with a particular focus on membrane technology.

Did You Know?

“The chromatographic purification of biomolecules by membrane chromatography reaches up to a degree of 99%, which makes it one of the most efficient methods of separating biomolecules in the manufacture of pharmaceuticals.” — Journal of Chromatography A

Segmental Market Size

The membrane chromatography market is growing at a rapid rate due to its essential role in the purification of biopharmaceuticals. Monoclonal antibodies and vaccines are particularly important in this respect, and the market is growing as a result of increasing demand. The market is also being driven by increasing demand for biopharmaceuticals, more stringent regulatory requirements for product purity, and the development of membrane chromatography to increase its efficiency and reduce its cost.

At the moment, membrane chromatography is in the process of being introduced on a large scale. It is a Merck and a Pall Corporation that are at the forefront in the development of this technique. Its main uses are in the pharmaceutical and biotechnological industries, where it is used for the purification of polypeptides and the removal of viruses. Its use is being hastened by the drive for sustainable production and the continuing effects of the world health crisis. Also, developments in membrane materials and designs, such as the development of high-throughput systems, will influence the future of this market.

Future Outlook

The market for membrane chromatography is forecast to grow at a CAGR of 16% from 2025 to 2035. This growth is driven by the growing demand for biopharmaceuticals and the need for more efficient purification processes in the production of monoclonal antibodies and other biopharmaceuticals. The regulatory framework for advanced manufacturing techniques is expected to support membrane chromatography, as it offers advantages in terms of scalability, faster throughput and lower operating costs, compared with other chromatography methods. By 2035, it is expected that membrane chromatography will account for about one-quarter of the total chromatography market, a sign of a high degree of penetration in the various applications, especially in the biopharmaceutical industry.

The development of new membrane materials and the improvement of the separation methods will further increase the efficiency and effectiveness of membrane chromatography. Nano-membrane technology, including the integration of nanomaterials and smart membranes, will improve the separation performance and throughput, and will thus attract more users. In addition, the trend of sustainable development in the pharmaceutical industry will also promote the development of membrane chromatography, which is more environmentally friendly than other methods. Furthermore, the trend towards personalization and biosimilars will also promote the development of membrane chromatography, which requires more flexible and efficient separation processes. In the future, membrane chromatography will play a more important role in the field of biopharmaceuticals.